Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/606614]Researchers: Prof Peter Rogers (Principal investigator) , Dr Carl Sprung , Prof Robert Lewis
Brief description Over 50% of cancer patients receive radiotherapy (RT). Tumour control using RT is limited by adverse normal tissue reactions. Unlike conventional RT machines, the Australian synchrotron has the capability to deliver strong radiation in very thin slices, termed microbeam RT (MRT). Tumour control has been obtained in animal models with a remarkable sparing of normal tissue using MRT. We will optimize MRT as a crucial step towards a potentially revolutionary cancer treatment.
Funding Amount $AUD 682,000.29
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 606614
- PURL : https://purl.org/au-research/grants/nhmrc/606614
